WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (71)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maldonado, R.
Right arrow Articles by Rodríguez de Fonseca, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maldonado, R.
Right arrow Articles by Rodríguez de Fonseca, F.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 1, 2002, 22(9):3326-3331

MINI REVIEW
Cannabinoid Addiction: Behavioral Models and Neural Correlates

Rafael Maldonado1 and Fernando Rodríguez de Fonseca2

1 Laboratori de Neurofarmacologia, Facultat de Cienciés de la Salut i de la Vida, Universitat Pompeu Fabra, 08003 Barcelona, Spain, and 2 Fundación Hospital Carlos Haya, Unidad de Investigación, 29010 Málaga, Spain

The use of cannabis sativa preparations as recreational drugs can be traced back to the earliest civilizations. However, animal models of cannabinoid addiction allowing the exploration of neural correlates of cannabinoid abuse have been developed only recently. We review these models and the role of the CB1 cannabinoid receptor, the main target of natural cannabinoids, and its interaction with opioid and dopamine transmission in reward circuits. Extensive reviews on the molecular basis of cannabinoid action are available elsewhere (Piomelli et al., 2000; Schlicker and Kathmann, 2001).


Copyright © 2002 Society for Neuroscience  0270-6474/02/2293326-06$05.00/0


This article has been cited by other articles:


Home page
FASEB J.Home page
N. Dobrosi, B. I. Toth, G. Nagy, A. Dozsa, T. Geczy, L. Nagy, C. C. Zouboulis, R. Paus, L. Kovacs, and T. Biro
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling
FASEB J, October 1, 2008; 22(10): 3685 - 3695.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Tonini, S. Ciardo, M. Cerovic, T. Rubino, D. Parolaro, M. Mazzanti, and R. Zippel
ERK-Dependent Modulation of Cerebellar Synaptic Plasticity after Chronic {Delta}9-Tetrahydrocannabinol Exposure
J. Neurosci., May 24, 2006; 26(21): 5810 - 5818.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Yao, K. McFarland, P. Fan, Z. Jiang, T. Ueda, and I. Diamond
Adenosine A2a blockade prevents synergy between {micro}-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats
PNAS, May 16, 2006; 103(20): 7877 - 7882.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Justinova, M. Solinas, G. Tanda, G. H. Redhi, and S. R. Goldberg
The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys
J. Neurosci., June 8, 2005; 25(23): 5645 - 5650.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Le Foll and S. R. Goldberg
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 875 - 883.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
F. RODRIGUEZ de FONSECA, I. DEL ARCO, F. J. BERMUDEZ-SILVA, A. BILBAO, A. CIPPITELLI, and M. NAVARRO
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
Alcohol Alcohol., January 1, 2005; 40(1): 2 - 14.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
A Dietrich and W F McDaniel
Endocannabinoids and exercise
Br. J. Sports Med., October 1, 2004; 38(5): 536 - 541.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers
PNAS, November 25, 2003; 100(24): 14379 - 14384.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Cami and M. Farre
Drug Addiction
N. Engl. J. Med., September 4, 2003; 349(10): 975 - 986.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev, July 1, 2003; 83(3): 1017 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. J. White
A Behavioral/Systems Approach to the Neuroscience of Drug Addiction
J. Neurosci., May 1, 2002; 22(9): 3303 - 3305.
[Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-